title: Pharmacokinetics of fluoxetine in pregnant baboons (Papio spp.).
abstract: Fluoxetine is used to treat a number of psychiatric conditions in humans and behavioral problems in animals. Its use in pregnancy must balance maternal benefit with potential risk to the fetus. Knowledge of adult and fetal drug disposition can assist clinicians in selecting therapy that minimizes adverse effects to the fetus. Nonhuman primate models are used frequently in drug dose-translation studies, and pregnancy in baboons has many similarities to human pregnancy. Accordingly, pharmacokinetic analysis of a series of fluoxetine and norfluoxetine administrations to pregnant baboons was performed. The mean maternal baboon steady-state clearance of fluoxetine (42 mL/min/kg) was considerably higher than that in humans. Norfluoxetine, the major active metabolite, had a higher metabolite-to-drug ratio (8.7) than that found in humans, particularly with oral dosing. These results are consistent with more extensive metabolism in baboons than in humans and leads to a higher clearance than would be expected from allometric scaling. Fetal-to-maternal fluoxetine and norfluoxetine ratios under steady-state conditions were similar to those in humans, with fetal concentrations of fluoxetine 42% and norfluoxetine 47% of maternal concentrations. The fetal clearance of fluoxetine (303 ± 176 mL/min) and norfluoxetine (450 mL/min) exceeded reported placental blood flow. Understanding these species-associated differences in metabolism is a prerequisite to extrapolating data between species. Nonetheless, nonhuman primates are likely to remain valuable models for pharmacokinetic studies during pregnancy, particularly those directed toward fetal neurodevelopmental effects. Our results also are applicable to determining appropriate dosing of nonhuman primates in clinical settings.
authors: Institute of Comparative Medicine, Columbia University, New York, New York, USA. rs2752@columbia.edu.
authors: Rivka L
authors: RL
authors: Shoulson
authors: Division of Neonatology, Columbia University, New York, New York, USA.
authors: Raymond L
authors: RL
authors: Stark
authors: Division of Neonatology, Columbia University, New York, New York, USA.
authors: Marianne
authors: M
authors: Garland
mesh_terms: D000818:Animals; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000493:pharmacokinetics*; D005260:Female; D005333:Fetus / Q000187:drug effects; D005473:Fluoxetine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000493:pharmacokinetics*; D006801:Humans; D010215:Papio; D011247:Pregnancy
chemical_list: D018687:Antidepressive Agents, Second-Generation; D005473:Fluoxetine; C036139:norfluoxetine
references: J Soc Gynecol Investig. 1997 Jul-Aug;4(4):183-90
references: 9292847
references: Drug Metab Dispos. 1998 Jan;26(1):20-4
references: 9443847
references: Crit Rev Toxicol. 1998 Jan;28(1):35-72
references: 9493761
references: J Pharmacol Exp Ther. 1998 Apr;285(1):54-62
references: 9535994
references: Obstet Gynecol Clin North Am. 1998 Mar;25(1):21-42
references: 9547758
references: Pediatr Res. 1998 Jul;44(1):47-53
references: 9667370
references: Depress Anxiety. 1998;8 Suppl 1:27-31
references: 9809211
references: Drug Metab Dispos. 2005 Jan;33(1):68-76
references: 15494471
references: Can J Psychiatry. 2004 Nov;49(11):726-35
references: 15633850
references: Comp Med. 2005 Feb;55(1):67-74
references: 15766212
references: Am J Psychiatry. 2005 Jun;162(6):1165-70
references: 15932816
references: Br J Clin Pharmacol. 2006 Feb;61(2):155-63
references: 16433870
references: Drug Metab Dispos. 2006 Apr;34(4):636-46
references: 16443669
references: FASEB J. 2008 Mar;22(3):659-61
references: 17942826
references: Breastfeed Med. 2008 Mar;3(1):44-52
references: 18333769
references: Drug Metab Dispos. 2008 Sep;36(9):1859-68
references: 18566040
references: J Am Assoc Lab Anim Sci. 2009 Mar;48(2):176-84
references: 19383215
references: Pharmacol Biochem Behav. 2009 May;92(3):469-73
references: 19463261
references: Clin Pharmacol Ther. 2009 Dec;86(6):672-7
references: 19890255
references: Drug Metab Dispos. 2010 Apr;38(4):545-53
references: 20071451
references: J Pharmacol Exp Ther. 2011 Jul;338(1):310-7
references: 21493752
references: J Clin Psychiatry. 2011 Jul;72(7):994-1001
references: 21824458
references: Pharmacology. 2011;88(1-2):44-9
references: 21757974
references: Placenta. 2012 Mar;33(3):137-42
references: 22265855
references: Gen Hosp Psychiatry. 2012 Mar-Apr;34(2):139-45
references: 22055329
references: Arch Dis Child Fetal Neonatal Ed. 2012 Nov;97(6):F472-6
references: 23080479
references: J Obstet Gynaecol Can. 2013 Apr;35(4):362-9
references: 23660045
references: Pharmacol Ther. 1980;10(2):301-28
references: 7413726
references: J Clin Pharmacol. 2000 Jan;40(1):58-66
references: 10631623
references: Am J Physiol Heart Circ Physiol. 2000 Sep;279(3):H1256-63
references: 10993792
references: Drug Metab Dispos. 2000 Oct;28(10):1187-91
references: 10997938
references: Acta Psychiatr Scand Suppl. 2000;403:26-34
references: 11019932
references: Isr J Psychiatry Relat Sci. 2000;37(3):205-22
references: 11084808
references: Ther Drug Monit. 2001 Apr;23(2):139-47
references: 11294514
references: BMJ. 2001 Aug 4;323(7307):257-60
references: 11485953
references: Pediatr Res. 2002 Apr;51(4):433-42
references: 11919327
references: J Clin Psychopharmacol. 2002 Dec;22(6):568-75
references: 12454556
references: J Pharmacol Exp Ther. 2003 Apr;305(1):197-204
references: 12649369
references: Clin Pharmacol Ther. 2003 Apr;73(4):330-7
references: 12709723
references: Am J Psychiatry. 2003 May;160(5):993-6
references: 12727706
references: Neurosci Biobehav Rev. 2003 Jan-Mar;27(1-2):33-44
references: 12732221
references: Yakugaku Zasshi. 2003 May;123(5):369-75
references: 12772594
references: Drug Metab Dispos. 2004 Feb;32(2):212-21
references: 14744943
references: J Pharmacol Exp Ther. 2004 Mar;308(3):965-74
references: 14634042
references: Int J Neuropsychopharmacol. 2004 Sep;7(3):329-34
references: 15035694
references: Science. 2004 Oct 29;306(5697):879-81
references: 15514160
references: Respir Physiol. 1969 Apr;6(3):271-83
references: 4976047
references: Respir Physiol. 1972 Jun;15(2):141-50
references: 5042162
references: Circ Res. 1976 Apr;38(4):262-6
references: 1260968
references: Drug Metab Dispos. 1982 Jul-Aug;10(4):382-6
references: 6126338
references: J Clin Psychiatry. 1985 Mar;46(3 Pt 2):14-9
references: 3871765
references: Am J Physiol. 1987 Nov;253(5 Pt 2):R735-9
references: 2825547
references: J Clin Psychopharmacol. 1987 Dec;7(6 Suppl):36S-43S
references: 2828437
references: Clin Pharmacokinet. 1988 Mar;14(3):156-70
references: 3286084
references: J Pharmacol Exp Ther. 1988 Nov;247(2):576-84
references: 3183953
references: Lab Anim Sci. 1989 Jan;39(1):25-32
references: 2918681
references: J Dev Physiol. 1991 Jan;15(1):33-44
references: 1678754
references: Eur J Biochem. 1991 Dec 5;202(2):583-8
references: 1722149
references: Clin Chem. 1992 Sep;38(9):1756-61
references: 1526010
references: J Clin Psychiatry. 1993 Sep;54 Suppl:14-34; discussion 55-6
references: 8407856
references: Am J Physiol. 1993 Sep;265(3 Pt 2):R706-14
references: 8214167
references: Clin Pharmacokinet. 1994 Mar;26(3):201-14
references: 8194283
references: Am J Psychiatry. 1994 Oct;151(10):1485-91
references: 7522411
references: Biochem Pharmacol. 1996 Feb 23;51(4):403-11
references: 8619884
references: Clin Pharmacol Ther. 1996 Nov;60(5):512-21
references: 8941024